METASTATIC CERVICAL CANCER
Clinical trials for METASTATIC CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CERVICAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for advanced cervical cancer patients
Disease control Recruiting nowThis study tests a combination of immunotherapy drugs (PD-1/PD-L1 inhibitors) with chemotherapy, with or without another drug called bevacizumab, in 120 adults with cervical cancer that has spread, persisted, or returned. The goal is to see if this approach helps patients live lo…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
New combo therapy offers hope for advanced cervical cancer patients
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with advanced cervical cancer that has not responded to previous treatment. The goal is to see if this combination can shrink tumors or slow cancer growth. About 35 participants will receive the …
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New combo aims to revive immune attack on hard-to-treat cervical cancer
Disease control Recruiting nowThis study tests a new drug, PRGN-2009, combined with pembrolizumab in 24 adults whose recurrent or metastatic cervical cancer no longer responds to pembrolizumab alone. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have HPV-…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for advanced cervical cancer: experimental drug takes on chemo in major trial
Disease control Recruiting nowThis study tests a new drug called SHR-A2102 against standard chemotherapy in people with recurrent or metastatic cervical cancer that has not responded to platinum-based chemo and immunotherapy. About 398 participants will be randomly assigned to receive either SHR-A2102 or a do…
Matched conditions: METASTATIC CERVICAL CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC